Press Release

View printer-friendly version

<< Back

AMAG Pharmaceuticals to Present at Leerink Partners Global Healthcare Conference

WALTHAM, Mass., Feb. 19, 2019 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) will present at the Leerink Partners Global Healthcare Conference on Wednesday, February 27, 2019. Ted Myles, chief financial officer and Julie Krop, MD, chief medical officer will participate in a fireside chat at 10:00 a.m. EST.

A live audio webcast will be accessible through the Investors section of the company’s website at www.amagpharma.com. A replay of the webcast will be archived on the company’s website for 30 days.

About AMAG
AMAG is a pharmaceutical company focused on bringing innovative products to patients with unmet medical needs. The company does this by leveraging its development and commercial expertise to invest in and grow its pharmaceutical products across a range of therapeutic areas, including women’s health. For additional company information, please visit www.amagpharma.com.

AMAG Pharmaceuticals® is a registered trademark of AMAG Pharmaceuticals, Inc.

AMAG Pharmaceuticals Contact:
Linda Lennox
908-627-3424

AMAG Pharmaceuticals logo

Source: AMAG Pharmaceuticals, Inc.